Cost-effectiveness of aspirin for the primary prevention of coronary heart disease

被引：0
|
作者：
Rodondi, Nicolas
Moran, Andrew
Coxson, Pamela G.
Lightwood, James
Williams, Lawrence W.
Cornuz, Jacques
Goldman, Lee
机构：
[1] Univ Lausanne, CH-1015 Lausanne, Switzerland
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 827
页数：1
相关论文
共 50 条
  • [21] Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
    Gaspoz, J
    Coxson, PG
    Goldman, PA
    Williams, LW
    Kuntz, KM
    Hunink, MGM
    Goldman, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23): : 1800 - 1806
  • [22] COST-EFFECTIVENESS OF ALTERNATIVE INTERVENTIONS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART-DISEASE
    CROWLEY, S
    DUNT, D
    DAY, N
    [J]. AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1995, 19 (04): : 336 - 346
  • [23] COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    GOLDMAN, L
    WEINSTEIN, MC
    GOLDMAN, PA
    WILLIAMS, LW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09): : 1145 - 1151
  • [24] Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease.
    Liew, D
    Vos, T
    Bertram, M
    Lim, S
    McNeil, JJ
    [J]. CIRCULATION, 2004, 109 (07) : E90 - E90
  • [25] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [26] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [27] COST-EFFECTIVENESS OF ANTIHYPERLIPEMIC THERAPY IN THE PREVENTION OF CORONARY HEART-DISEASE - THE CASE OF CHOLESTYRAMINE
    OSTER, G
    EPSTEIN, AM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (17): : 2381 - 2387
  • [28] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    [J]. CIRCULATION, 2004, 110 (17) : 802 - 802
  • [29] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [30] COST-EFFECTIVENESS PERSPECTIVES IN CORONARY HEART-DISEASE
    GOLDMAN, L
    [J]. AMERICAN HEART JOURNAL, 1990, 119 (03) : 733 - 740
12345